Presentation is loading. Please wait.

Presentation is loading. Please wait.

Recurrence of pulmonary vein conduction and atrial fibrillation after pulmonary vein isolation for atrial fibrillation: A randomized trial of the ostial.

Published byNorman Gaines Modified over 7 years ago

Similar presentations

Presentation on theme: "Recurrence of pulmonary vein conduction and atrial fibrillation after pulmonary vein isolation for atrial fibrillation: A randomized trial of the ostial."— Presentation transcript:

1 Recurrence of pulmonary vein conduction and atrial fibrillation after pulmonary vein isolation for atrial fibrillation: A randomized trial of the ostial versus the extraostial ablation strategy  Brian Nilsson, MD, Xu Chen, MD, DMSc, Steen Pehrson, MD, DMSc, Lars Køber, MD, DMSc, Jørgen Hilden, MD, Jesper H. Svendsen, MD, DMSc  American Heart Journal  Volume 152, Issue 3, Pages 537.e1-537.e8 (September 2006) DOI: /j.ahj Copyright © Terms and Conditions

2 Figure 1 Freedom from recurrent symptomatic AF after PV isolation when one reablation is allowed. On the x-axis, day 0 refers to start of the follow-up (30 days after the ablation). Dotted line indicates extraostial PV isolation; solid line, ostial PV isolation. American Heart Journal  , 537.e1-537.e8DOI: ( /j.ahj ) Copyright © Terms and Conditions

3 Figure 2 Freedom from recurrent symptomatic AF after PV isolation when one reablation is allowed. On the x-axis, day 0 refers to start of the follow-up (30 days after the ablation). Dotted line indicates no structural cardiac disease; solid line, structural heart disease. American Heart Journal  , 537.e1-537.e8DOI: ( /j.ahj ) Copyright © Terms and Conditions

4 Figure 3 Freedom from recurrent symptomatic AF after PV isolation when one reablation is allowed. On the x-axis, day 0 refers to start of the follow-up (30 days after the ablation). Dotted line indicates paroxysmal AF; solid line, persistent AF. American Heart Journal  , 537.e1-537.e8DOI: ( /j.ahj ) Copyright © Terms and Conditions

Download ppt "Recurrence of pulmonary vein conduction and atrial fibrillation after pulmonary vein isolation for atrial fibrillation: A randomized trial of the ostial."

Similar presentations

Attraction of Rotors to the Pulmonary Veins in Paroxysmal Atrial Fibrillation: A Modeling Study Conrado J. Calvo, Makarand Deo, Sharon Zlochiver, José.

Attraction of Rotors to the Pulmonary Veins in Paroxysmal Atrial Fibrillation: A Modeling Study Conrado J. Calvo, Makarand Deo, Sharon Zlochiver, José.
Pulmonary vein triggers play an important role in the initiation of atrial flutter: Initial results from the prospective randomized Atrial Fibrillation.

Pulmonary vein triggers play an important role in the initiation of atrial flutter: Initial results from the prospective randomized Atrial Fibrillation.
Catheter Ablation of Atrial Fibrillation by Roderick Tung, Eric Buch, and Kalyanam Shivkumar Circulation Volume 126(2):223-229 July 10, 2012 Copyright.

Catheter Ablation of Atrial Fibrillation by Roderick Tung, Eric Buch, and Kalyanam Shivkumar Circulation Volume 126(2): July 10, 2012 Copyright.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Comparison of Radiofrequency Catheter Ablation of.

Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Comparison of Radiofrequency Catheter Ablation of.
Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: Data from the Mode Selection Trial (MOST)  Kirsten E. Fleischmann,

Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: Data from the Mode Selection Trial (MOST)  Kirsten E. Fleischmann,
An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist.

An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist.
Agreement between public register and adjudication committee outcome in a cardiovascular randomized clinical trial  Erik Kjøller, MD, DMSc, Jørgen Hilden,

Agreement between public register and adjudication committee outcome in a cardiovascular randomized clinical trial  Erik Kjøller, MD, DMSc, Jørgen Hilden,
Colloquium on Therapy of Right Heart Failure

Colloquium on Therapy of Right Heart Failure
Force- and relaxation-frequency relations in patients with diastolic heart failure  Takashi Yamanaka, MD, Katsuya Onishi, MD, FACC, Masaki Tanabe, MD,

Force- and relaxation-frequency relations in patients with diastolic heart failure  Takashi Yamanaka, MD, Katsuya Onishi, MD, FACC, Masaki Tanabe, MD,
Neutral impact on systolic and diastolic cardiac function of 2 years of intensified multi- intervention in type 2 diabetes: The randomized controlled Asker.

Neutral impact on systolic and diastolic cardiac function of 2 years of intensified multi- intervention in type 2 diabetes: The randomized controlled Asker.
Comparable three months' outcome of total arterial revascularization versus conventional coronary surgery: Copenhagen Arterial Revascularization Randomized.

Comparable three months' outcome of total arterial revascularization versus conventional coronary surgery: Copenhagen Arterial Revascularization Randomized.
Rationale and design of the FreezeAF trial: A randomized controlled noninferiority trial comparing isolation of the pulmonary veins with the cryoballoon.

Rationale and design of the FreezeAF trial: A randomized controlled noninferiority trial comparing isolation of the pulmonary veins with the cryoballoon.
Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study.

Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study.
Impact of weight reduction on pericardial adipose tissue and cardiac structure in patients with atrial fibrillation  Hany S. Abed, BPharm, MBBS, PhD,

Impact of weight reduction on pericardial adipose tissue and cardiac structure in patients with atrial fibrillation  Hany S. Abed, BPharm, MBBS, PhD,
Adjunctive therapy with interferon-gamma for the treatment of pulmonary tuberculosis: a systematic review  X.-F. Gao, Z.-W. Yang, J. Li  International.

Adjunctive therapy with interferon-gamma for the treatment of pulmonary tuberculosis: a systematic review  X.-F. Gao, Z.-W. Yang, J. Li  International.
Hyperbaric Oxygenation in Cardiac and Pulmonary Disease

Hyperbaric Oxygenation in Cardiac and Pulmonary Disease
New-onset Atrial Fibrillation Predicts Heart Failure Progression

New-onset Atrial Fibrillation Predicts Heart Failure Progression
Evaluating the safety and efficacy of sodium-restricted/Dietary Approaches to Stop Hypertension diet after acute decompensated heart failure hospitalization:

Evaluating the safety and efficacy of sodium-restricted/Dietary Approaches to Stop Hypertension diet after acute decompensated heart failure hospitalization:
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 

Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation  Anh L. Bui, MD, Maria.

Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation  Anh L. Bui, MD, Maria.

Similar presentations

Ads by Google